Published Oct 3, 2017
#131 Faster Acting Insulin is Here!
Explore the revolutionary impact of Fiasp, a game-changing faster-acting insulin, as Novo Nordisk's Todd Hobbs reveals its development journey and market adaptation, while the podcast delves into Dexcom's technological advancements in real-time diabetes management.
Topics covered
Popular Clips
Questions from this episode
Episode Highlights
Related Episodes
#121 Insulin, Insulin, Insulin
Answers 383 questions
#125 Injecting In A Pump World
Answers 383 questions
#160 Diabetes Fast Forward
Answers 383 questions#011 Bold with Insulin
Answers 383 questions#831 Best of Juicebox: Bold With Insulin
Answers 383 questions
#937 Fastidious
Answers 383 questions
#646 More Affordable Insulin Is Coming
Answers 383 questions#723 Bold Beginnings: Long Acting Insulin
Answers 383 questions
#112 Bigfoot Biomedical Returns
Answers 383 questions
#721 Cutting It Up
Answers 383 questions
#434 Splitting Long Acting Insulin
Answers 383 questions
#145 Is Your Insulin Compromised?
Answers 383 questions
#783 Survey Says
Answers 383 questions#100 Bold With Insulin: Revisited
Answers 383 questions
#1029 Glucagon Story: Sarah
Answers 383 questions